Beta Bionics, Inc. — insider transactions

2 transactions on record · CIK 1674632

Aggregates

computed from the filings below

Purchases, 12m

0

count of open-market buys

Sales, 12m

2

count of open-market sales

Buy / sell ratio, 12m

0.00

purchases per sale

Distinct insiders, 12m

2

Bought, 3m

$0

Sold, 3m

$794K

Median disclosure lag

1.0 d

trade date to filing date

Largest single trade, 24m

$680.7K

2026-09-09

Director share, 12m

50.0%

of transactions where role is stated

Current run

2 sells

consecutive same-direction transactions

Net 3m flow

-$794K

purchases minus sales

Total on record

2

Transactions

2 most recent shown

Disclosed	Traded	Lag, d	Insider	Role	Transaction	Shares	Price	Value	Source
2026-09-10	2026-09-09	1	Hopman Mark	Chief Commercial Officer	Open market sale	36,870	$18.46	$680.7K	filing
2026-09-04	2026-09-03	1	Saint Sean	Director, CEO	Open market sale	5,641	$20.08	$113.3K	filing

Source: U.S. Securities and Exchange Commission, EDGAR

Beta Bionics, Inc. insider transactions — 2 filings on record — investment.com